6 days ago
Dr. Ryan Beck: Dry Eye Isn't Going Away Anytime Soon
Dry Eye Disease affects millions of Americans, yet many patients still think the only solution is to grab a bottle of artificial tears from the pharmacy shelf. According to Dr. Ryan Beck, a leading optometrist recently featured on The Dry Eye Podcast by Broadry, the reality is that treatment options have evolved far beyond basic drops—ushering in an era of high-tech, in-office procedures that are transforming patient outcomes.
'We start with simple management tools—over-the-counter drops, nutraceuticals, lid cleansers, and wipes,' Beck says. 'But today, there's an entire spectrum of therapies available that address the root causes of dry eye.'
From Restasis to a Full Pharmaceutical Arsenal
When Restasis launched in the early 2000s, it was the only FDA-approved prescription option for chronic dry eye. Fast-forward to today, and patients have access to a range of medications that reduce inflammation, improve tear production, and protect the ocular surface. Newer prescription drops are more targeted, faster-acting, and in some cases, better tolerated—giving practitioners more flexibility to tailor treatments.
In-Office Devices: Borrowing From Aesthetics
Beyond pharmaceuticals, Beck highlights a trend that's crossing over from the beauty and dermatology world. Intense Pulse Light (IPL) therapy (invented by Dr. Rolando Toyos) originally designed for skin rejuvenation, has become a powerful tool in treating meibomian gland dysfunction, a leading cause of dry eye. By reducing inflammation and improving oil flow in the eyelids, IPL addresses tear film stability at its source.
Another innovation: radiofrequency (RF) devices that stimulate collagen production and tighten skin around the eyes. 'A better eyelid seal means a better blink,' Beck explains, 'and that's critical for tear retention.'
Photobiomodulation
The red-light therapy devices that have exploded in the hair restoration market are also making waves in dry eye treatment. Photobiomodulation appears to boost oil gland function, potentially reducing evaporative dry eye symptoms. Early research is promising, and many clinics are already integrating specific light technology into their treatment menus.
Why This Matters Now
With dry eye prevalence increasing, due in part to screen-heavy lifestyles, environmental factors, and aging populations, the demand for more effective, lasting treatments is only growing. 'Dry eye isn't going away anytime soon,' says Beck. 'The better we can manage it, the happier our patients will be.'
In other words, the future of dry eye care lies in personalization, prevention, and a willingness to embrace technology from unexpected places. And for patients, that means relief is no longer limited to what's on the drugstore shelf.
